Compounds
US11253499B2 · kind B2 · utility
0Cited by
1References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 15, 2018 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Aug 15, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by Mycobacterium, such as tuberculosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.